SCHEMBL24906148

SCHEMBL24906148

O=C(Nc1ccc(O)cc1Cl)C1CC1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.57
KMT2A Q03164 4/20 0.56
NPC1 O15118 1/20 0.55
RAB9A P51151 1/20 0.55
MEN1 O00255 2/20 0.54
GAA P10253 2/20 0.54
PDK1 Q15118 1/20 0.49
PDK2 Q15119 1/20 0.49
PDK3 Q15120 1/20 0.49
PDK4 Q16654 1/20 0.49
LMNA P02545 1/20 0.49
HPGD P15428 1/20 0.49
ALOX15 P16050 1/20 0.49
ALOX12 P18054 1/20 0.49
HTT P42858 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
GRM4 Q14833 1/20 0.48
TYK2 P29597 1/20 0.48
MAPK1 P28482 2/20 0.48
S1PR1 P21453 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3711806 0.85 RAB9A (0.73) ALDH1A1KMT2ANPC1RAB9AMEN1
SCHEMBL31692494 0.82 HTT (0.64) ALDH1A1KMT2ANPC1RAB9AMEN1
Bicarbonate SCHEMBL19664773 0.82 RAB9A (0.69) ALDH1A1KMT2ANPC1RAB9AMEN1
SCHEMBL4604094 0.80 KDM4E (0.57) ALDH1A1KMT2ARAB9AMEN1GAA
SCHEMBL28592805 0.79 CYP2C19 (0.64) ALDH1A1KMT2ANPC1RAB9AMEN1
SCHEMBL13716462 0.78 RAB9A (0.64) ALDH1A1KMT2ANPC1RAB9ALMNA
SCHEMBL1322743 0.78 HTT (0.71) ALDH1A1KMT2ANPC1RAB9AMEN1
SCHEMBL29419622 0.78 HTT (0.71) ALDH1A1KMT2ANPC1RAB9AMEN1
SCHEMBL3717777 0.77 PDK1 (0.55) ALDH1A1KMT2ARAB9AMEN1PDK1
SCHEMBL28895412 0.76 HTT (0.54) ALDH1A1NPC1RAB9APDK1PDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230014962-A1 Quinoline compound and use thereof SKYRUN PHARMA CO LTD (CN) 2023-01-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230014962-A1 Quinoline compound and use thereof FGFR4, FGFR1, FGFR3 ALDH1A1 1995/4885KMT2A 1507/4885NPC1 3041/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.